Gerson, James N <br/><br/>
Survival Outcomes of Younger Patients With Mantle Cell Lymphoma Treated in the Rituximab Era.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  02 2019 
 - 471-480 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.18.00690  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Age Factors<br/>Aged<br/>Antineoplastic Agents, Immunological--adverse effects<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Female<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Lymphoma, Mantle-Cell--mortality<br/>Male<br/>Middle Aged<br/>North America<br/>Progression-Free Survival<br/>Retrospective Studies<br/>Risk Assessment<br/>Risk Factors<br/>Rituximab--adverse effects<br/>Time Factors<br/>Transplantation, Autologous<br/>Young Adult